1. |
|
|
2. |
|
|
3. |
|
|
4. |
|
|
5. |
|
|
6. |
|
|
7. |
|
|
8. |
|
|
9. |
|
|
10. |
|
|
11. |
|
|
12. |
|
|
13. |
|
|
14. |
|
|
15. |
|
|
16. |
|
|
17. |
|
|
18. |
|
|
19. |
|
|
20. |
|
|
21. |
|
|
22. |
- van Veldhuisen, DJ, et al.
(författare)
-
Treatment of chronic heart failure with aldosterone-blocking agents
- 2011
-
Ingår i: EUROPEAN HEART JOURNAL SUPPLEMENTS. - 1520-765X. ; 13:B
-
Tidskriftsartikel (refereegranskat)abstract
- Abstract: Three large randomized trials in advanced heart failure (RALES), in heart failure after myocardial infarction (EPHESUS), and most recently mild heart failure (EMPHASIS-HF) have firmly established the place of aldosterone-blocking agents in patients with heart failure. In this paper we will shortly review these 3 trials, and discuss their place in current, and their potential place in future guidelines.
|
|
23. |
|
|